RecruitingPhase 2Phase 3NCT06050148
Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
Sponsor
Helsinki University Central Hospital
Enrollment
100 participants
Start Date
Aug 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 90 Years
Inclusion Criteria3
- Female subjects aged ≥18
- History of recurrent UTI: at least two episodes of UTI over the past 6 months or at least three episodes over the past year, most recent episode within the past three months
- Written informed consent
Exclusion Criteria6
- Suspected non-compliance
- Diagnosis of a gastrointestinal disease
- Pregnancy
- Immunosuppression
- Any kind of permanent urinary catheter or intermittent urinary catheterization
- Any other criteria which, in the investigator's opinion, would compromise the ability of the subject to participate in the study, the subject's well-being, or the outcome of the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALFeacal microbial transplantation (FMT)
Feacal microbial transplantation (FMT)
OTHERPlacebo transplantation (PT)
Transplantation with coloured 0,9% NaCl-solution
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06050148
Related Trials
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
NCT048078941 location
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
NCT069406221 location
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
NCT056523743 locations
The Effect of ASTARTE™ on Recurrent Urinary Tract Infection
NCT055536521 location